ASX:GSS Genetic Signatures (GSS) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Genetic Signatures Stock (ASX:GSS) 30 days 90 days 365 days Advanced Chart Get Genetic Signatures alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewGenetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia.Read More… Receive GSS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genetic Signatures and its competitors with MarketBeat's FREE daily newsletter. Email Address GSS Stock News HeadlinesPleasing Signs As A Number Of Insiders Buy Genetic Signatures StockJanuary 1, 2025 | uk.finance.yahoo.comGenetic Signatures Limited (ASX:GSS) is favoured by institutional owners who hold 53% of the companyNovember 20, 2024 | finance.yahoo.comI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. January 14, 2025 | Porter & Company (Ad)Health Check: Painchek strives to Make American Aged Folk Comfortable AgainNovember 20, 2024 | msn.comGenetic Signatures Reports Strong Sales Boost Amid U.S. ExpansionOctober 31, 2024 | markets.businessinsider.comGenetic variants in melatonin receptor linked to idiopathic osteoporosisOctober 24, 2024 | msn.comGenetic screening study casts a wide net to find psychopathology risksOctober 17, 2024 | msn.comGene editing approach helps launch first-in-human clinical trial for rare genetic diseaseOctober 16, 2024 | msn.comSee More Headlines GSS Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Genetic Signatures own? Based on aggregate information from My MarketBeat watchlists, some other companies that Genetic Signatures investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU) and VelocityShares 1x Long VSTOXX Futures ETN (EVIX). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:GSS CUSIPN/A CIKN/A Webwww.geneticsignatures.com Phone61 2 9870 7580FaxN/AEmployees1,626Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-17,860,000.00 Net Margins-129.74% Pretax MarginN/A Return on Equity-34.34% Return on Assets-19.69% Debt Debt-to-Equity Ratio2.00 Current Ratio10.04 Quick Ratio8.54 Sales & Book Value Annual Sales$13.77 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.28 per share Price / BookN/AMiscellaneous Outstanding Shares226,870,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.05 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (ASX:GSS) was last updated on 1/14/2025 by MarketBeat.com Staff From Our PartnersStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in JanuaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genetic Signatures Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Genetic Signatures With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
